دورية أكاديمية

In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies.

التفاصيل البيبلوغرافية
العنوان: In Silico Evaluation of the Potential Association of the Pathogenic Mutations of Alpha Synuclein Protein with Induction of Synucleinopathies.
المؤلفون: Elnageeb ME; Department of Basic Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia., Elfaki I; Department of Biochemistry, Faculty of Science, University of Tabuk, P.O. Box 741, Tabuk 71491, Saudi Arabia., Adam KM; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia., Ahmed EM; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia.; Department of Clinical Chemistry, Faculty of Medical Laboratory Sciences, University of El Imam El Mahdi, Kosti 27711, Sudan., Elkhalifa EM; Department of Anatomy, Faculty of Medicine and Health Sciences, Nile Valley University, Atbara 46611, Sudan., Abuagla HA; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia., Ahmed AAEM; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia., Ali EW; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia., Eltieb EI; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia., Edris AM; Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, P.O. Box 551, Bisha 61922, Saudi Arabia.
المصدر: Diseases (Basel, Switzerland) [Diseases] 2023 Sep 06; Vol. 11 (3). Date of Electronic Publication: 2023 Sep 06.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101636232 Publication Model: Electronic Cited Medium: Print ISSN: 2079-9721 (Print) Linking ISSN: 20799721 NLM ISO Abbreviation: Diseases Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI AG, [2013]-
مستخلص: Alpha synuclein (α-Syn) is a neuronal protein encoded by the SNCA gene and is involved in the development of Parkinson's disease (PD). The objective of this study was to examine in silico the functional implications of non-synonymous single nucleotide polymorphisms (nsSNPs) in the SNCA gene. We used a range of computational algorithms such as sequence conservation, structural analysis, physicochemical properties, and machine learning. The sequence of the SNCA gene was analyzed, resulting in the mapping of 42,272 SNPs that are classified into different functional categories. A total of 177 nsSNPs were identified within the coding region; there were 20 variants that may influence the α-Syn protein structure and function. This identification was made by employing different analytical tools including SIFT, PolyPhen2, Mut-pred, SNAP2, PANTHER, PhD-SNP, SNP&Go, MUpro, Cosurf, I-Mut, and HOPE. Three mutations, V82A, K80E, and E46K, were selected for further examinations due to their spatial positioning within the α-Syn as determined by PyMol. Results indicated that these mutations may affect the stability and function of α-Syn. Then, a molecular dynamics simulation was conducted for the SNCA wildtype and the four mutant variants (p.A18G, p.V82A, p.K80E, and p.E46K). The simulation examined temperature, pressure, density, root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), solvent-accessible surface area (SASA), and radius of gyration (Rg). The data indicate that the mutations p.V82A, p.K80E, and p.E46K reduce the stability and functionality of α-Syn. These findings highlight the importance of understanding the impact of nsSNPs on α-syn structure and function. Our results required verifications in further protein functional and case-control studies. After being verified these findings can be used in genetic testing for the early diagnosis of PD, the evaluation of the risk factors, and therapeutic approaches.
References: Curr Diabetes Rev. 2020;16(8):881-888. (PMID: 31749428)
PLoS One. 2014 Dec 05;9(12):e112456. (PMID: 25479359)
Biophys J. 2007 Jul 1;93(1):225-31. (PMID: 17172302)
Front Pharmacol. 2020 Apr 23;11:356. (PMID: 32390826)
Anal Biochem. 2011 Feb 1;409(1):159-61. (PMID: 20950582)
Nat Rev Dis Primers. 2021 Jul 1;7(1):47. (PMID: 34210995)
Nat Rev Neurosci. 2013 Jan;14(1):38-48. (PMID: 23254192)
Curr Issues Mol Biol. 2021 Nov 02;43(3):1859-1875. (PMID: 34889890)
Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):4971-4982. (PMID: 32075919)
Diabetes. 2017 Nov;66(11):2888-2902. (PMID: 28566273)
Cell Death Dis. 2023 Mar 1;14(3):176. (PMID: 36859484)
Protein Sci. 2022 Jan;31(1):8-22. (PMID: 34717010)
Sci Rep. 2017 Jul 26;7(1):6525. (PMID: 28747718)
Front Neurosci. 2019 Apr 18;13:381. (PMID: 31057362)
Signal Transduct Target Ther. 2020 Sep 23;5(1):213. (PMID: 32968059)
Nucleic Acids Res. 2003 Jul 1;31(13):3812-4. (PMID: 12824425)
ACS Chem Neurosci. 2022 Nov 2;13(21):3126-3137. (PMID: 36278939)
J Org Chem. 2020 Feb 7;85(3):1548-1555. (PMID: 31809571)
Neuron. 2018 Oct 10;100(1):75-90.e5. (PMID: 30308173)
BMC Mol Cell Biol. 2020 Mar 6;21(1):12. (PMID: 32143568)
Asian Pac J Cancer Prev. 2018 Aug 24;19(8):2057-2070. (PMID: 30139042)
Mol Brain. 2017 Nov 28;10(1):53. (PMID: 29183391)
Sci Rep. 2019 Dec 16;9(1):19144. (PMID: 31844149)
Biomolecules. 2020 Mar 03;10(3):. (PMID: 32138193)
Front Neurol. 2020 Jul 28;11:682. (PMID: 32849182)
RSC Adv. 2019 Dec 24;10(1):215-227. (PMID: 35492549)
Cell Biochem Biophys. 2013 Jun;66(2):249-63. (PMID: 23161105)
Nat Commun. 2020 Nov 20;11(1):5918. (PMID: 33219223)
Mov Disord. 2021 Jul;36(7):1624-1633. (PMID: 33617693)
Sci Rep. 2023 Apr 25;13(1):6774. (PMID: 37185285)
Comput Biol Chem. 2019 Jun;80:31-45. (PMID: 30884445)
Biomolecules. 2015 Mar 25;5(2):282-305. (PMID: 25816357)
J Parkinsons Dis. 2017;7(s1):S51-S69. (PMID: 28282814)
Biology (Basel). 2020 May 19;9(5):. (PMID: 32438686)
Front Bioeng Biotechnol. 2020 Oct 16;8:588947. (PMID: 33178678)
Ageing Res Rev. 2021 Sep;70:101391. (PMID: 34119687)
J Biol Chem. 2022 Apr;298(4):101791. (PMID: 35247388)
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10328-33. (PMID: 27573854)
BMC Bioinformatics. 2010 Nov 08;11:548. (PMID: 21059217)
Curr Drug Metab. 2020;21(14):1152-1160. (PMID: 33115391)
J Clin Invest. 2008 Feb;118(2):777-88. (PMID: 18172548)
Medicina (Kaunas). 2022 Nov 16;58(11):. (PMID: 36422197)
Mol Neurodegener. 2015 Aug 27;10:41. (PMID: 26306801)
Nat Commun. 2022 Jul 6;13(1):3895. (PMID: 35794153)
Cold Spring Harb Perspect Med. 2018 Jul 2;8(7):. (PMID: 28213437)
Mol Neurodegener. 2019 Jul 22;14(1):29. (PMID: 31331359)
Bioinformatics. 2006 Nov 15;22(22):2729-34. (PMID: 16895930)
PLoS One. 2022 May 4;17(5):e0267084. (PMID: 35507592)
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W529-33. (PMID: 20478830)
Mol Neurodegener. 2021 Dec 18;16(1):83. (PMID: 34922583)
Cancers (Basel). 2023 Feb 17;15(4):. (PMID: 36831624)
Nat Commun. 2020 May 26;11(1):2643. (PMID: 32457390)
Hum Genomics. 2022 Apr 2;16(1):11. (PMID: 35366956)
Hum Mutat. 2009 Aug;30(8):1237-44. (PMID: 19514061)
Transl Neurodegener. 2020 Jan 17;9:5. (PMID: 31988747)
J Pept Sci. 2013 Jun;19(6):362-9. (PMID: 23596087)
Pharmaceutics. 2021 Dec 21;14(1):. (PMID: 35056897)
J Pers Med. 2019 Jun 06;9(2):. (PMID: 31174318)
BMC Genomics. 2015;16 Suppl 8:S1. (PMID: 26110438)
Eur J Neurol. 2020 Jan;27(1):27-42. (PMID: 31631455)
Front Mol Neurosci. 2018 Oct 25;11:391. (PMID: 30410434)
J Parkinsons Dis. 2015;5(4):699-713. (PMID: 26407041)
Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20. (PMID: 23315928)
PLoS One. 2022 Jan 21;17(1):e0261829. (PMID: 35061689)
Transl Neurodegener. 2017 Oct 25;6:28. (PMID: 29090092)
فهرسة مساهمة: Keywords: Parkinson’s disease (PD); SNCA gene non-synonymous single nucleotide polymorphisms (nsSNPs); alpha-synuclein (α-Syn) protein; bioinformatics; synucleinopathies
تواريخ الأحداث: Date Created: 20230927 Latest Revision: 20231003
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10529770
DOI: 10.3390/diseases11030115
PMID: 37754311
قاعدة البيانات: MEDLINE
الوصف
تدمد:2079-9721
DOI:10.3390/diseases11030115